Dolby Laboratories, Inc.

For the period ended Dec 26, 2025. Filed Jan 29, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 26, 2025 · Filed Jan 29, 2026

DLB$64.67-0.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Interim Condensed Consolidated Balance Sheets

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	December 26,2025	September 26,2025
ASSETS
Current assets:
Cash and cash equivalents	$643,845	$701,893
Restricted cash	83,721	91,468
Short-term investments	739	703
Accounts receivable, net of allowance for credit losses of $8,116 and $7,221	373,091	331,096
Contract assets, net of allowance for credit losses of $91 and $101	198,266	180,804
Inventories, net	31,264	30,424
Prepaid expenses and other current assets	77,136	51,873
Total current assets	1,408,062	1,388,261
Long-term investments	85,022	80,205
Property, plant, and equipment, net	466,720	470,608
Operating lease right-of-use assets	35,569	33,204
Intangible assets, net	364,016	397,057
Goodwill	530,304	529,900
Deferred taxes	214,346	214,361
Other non-current assets	88,084	114,164
Total assets	$3,192,123	$3,227,760
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$8,668	$17,840
Accrued liabilities	376,212	369,256
Income taxes payable	11,208	8,928
Contract liabilities	37,094	31,382
Operating lease liabilities	10,325	10,384
Total current liabilities	443,507	437,790
Non-current contract liabilities	25,159	29,687
Non-current operating lease liabilities	30,314	28,494
Other non-current liabilities	90,272	99,843
Total liabilities	589,252	595,814
Commitments and Contingencies (See Note 15)
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 60,877,565 shares issued and outstanding as of December 26, 2025 and 60,802,616 as of September 26, 2025	54	54
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 34,655,045 shares issued and outstanding as of December 26, 2025 and 34,660,045 as of September 26, 2025	40	40
Retained earnings	2,604,358	2,634,980
Accumulated other comprehensive loss	(10,777)	(12,517)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,593,675	2,622,557
Noncontrolling interest	9,196	9,389
Total stockholders’ equity	2,602,871	2,631,946
Total liabilities and stockholders’ equity	$3,192,123	$3,227,760

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.